Mesa Laboratories Inc
MLAB80.470USD
-0.200-0.25%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
443.45MMarket Cap
LossP/E TTM
More Details of Mesa Laboratories Inc Company
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Mesa Laboratories Inc Info
Ticker SymbolMLAB
Company nameMesa Laboratories Inc
IPO dateFeb 29, 1984
CEOOwens (Gary M)
Number of employees730
Security typeOrdinary Share
Fiscal year-endFeb 29
Address12100 W 6th Ave
CityLAKEWOOD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code80228
Phone13039878000
Websitehttps://mesalabs.com
Ticker SymbolMLAB
IPO dateFeb 29, 1984
CEOOwens (Gary M)
Company Executives of Mesa Laboratories Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+8.45%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.78%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%
By RegionUSD
Name
Revenue
Proportion
United States
27.65M
46.43%
Other
26.47M
44.45%
China
5.43M
9.12%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Discrete Revenues- Consumables
35.77M
60.08%
Discrete Revenues- Hardware and Software
12.57M
21.11%
Contracted Revenues- Services
7.90M
13.26%
Discrete Revenues- Services
3.31M
5.55%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
Other
73.26%
Shareholders
Shareholders
Proportion
Conestoga Capital Advisors, LLC
7.72%
BlackRock Institutional Trust Company, N.A.
5.93%
The Vanguard Group, Inc.
5.83%
Ranger Investment Management, L.P.
3.80%
Geneva Capital Management LLC
3.47%
Other
73.26%
Shareholder Types
Shareholders
Proportion
Investment Advisor
37.82%
Investment Advisor/Hedge Fund
35.41%
Hedge Fund
13.57%
Individual Investor
5.44%
Research Firm
4.14%
Bank and Trust
0.88%
Pension Fund
0.84%
Sovereign Wealth Fund
0.06%
Insurance Company
0.03%
Other
1.82%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
387
5.12M
92.75%
-722.23K
2025Q2
399
5.60M
101.85%
-541.53K
2025Q1
415
5.83M
106.86%
-307.02K
2024Q4
405
5.76M
105.94%
-86.00K
2024Q3
413
5.30M
97.90%
-538.92K
2024Q2
412
5.31M
98.26%
-376.30K
2024Q1
404
5.28M
97.81%
-366.78K
2023Q4
400
5.27M
97.82%
-295.14K
2023Q3
392
5.33M
99.02%
-178.63K
2023Q2
390
5.31M
98.92%
-355.72K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Conestoga Capital Advisors, LLC
566.15K
10.29%
-5.21K
-0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
708.66K
12.88%
-30.52K
-4.13%
Jun 30, 2025
The Vanguard Group, Inc.
388.10K
7.05%
+4.80K
+1.25%
Jun 30, 2025
Ranger Investment Management, L.P.
214.29K
3.9%
-16.70K
-7.23%
Jun 30, 2025
Geneva Capital Management LLC
199.09K
3.62%
+9.78K
+5.17%
Jun 30, 2025
Royce Investment Partners
247.61K
4.5%
-23.51K
-8.67%
Jun 30, 2025
Owens (Gary M)
136.70K
2.48%
+13.43K
+10.89%
Jun 21, 2025
Janus Henderson Investors
113.28K
2.06%
+32.54K
+40.30%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
145.94K
2.65%
-1.85K
-1.25%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
VictoryShares Small Cap Free Cash Flow ETF
0.22%
Principal U.S. Small-Cap ETF
0.1%
Vanguard US Quality Factor ETF
0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
WisdomTree US SmallCap Fund
0.05%
Avantis US Small Cap Equity ETF
0.05%
WisdomTree U.S. SmallCap Dividend Fund
0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
View more
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.22%
Principal U.S. Small-Cap ETF
Proportion0.1%
Vanguard US Quality Factor ETF
Proportion0.09%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proportion0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.06%
WisdomTree US SmallCap Fund
Proportion0.05%
Avantis US Small Cap Equity ETF
Proportion0.05%
WisdomTree U.S. SmallCap Dividend Fund
Proportion0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.02%
Dividend
A total of
16.82M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Oct 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2025 going ex on Nov 28, 2025
Nov 28, 2025
Dec 15, 2025
Nov 28, 2025
Jul 03, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
Apr 07, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 16, 2025 going ex on May 30, 2025
May 30, 2025
Jun 16, 2025
May 30, 2025
Jan 08, 2025
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 17, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 17, 2025
Feb 28, 2025
Oct 02, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 16, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 16, 2024
Nov 29, 2024
Jul 10, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 16, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 16, 2024
Aug 30, 2024
Apr 05, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 14, 2024 going ex on May 31, 2024
May 31, 2024
Jun 14, 2024
May 31, 2024
Jan 04, 2024
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 15, 2024 going ex on Feb 28, 2024
Feb 29, 2024
Mar 15, 2024
Feb 28, 2024
Oct 03, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2023 going ex on Nov 29, 2023
Nov 30, 2023
Dec 15, 2023
Nov 29, 2023
Jul 05, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2023 going ex on Aug 30, 2023
Aug 31, 2023
Sep 15, 2023
Aug 30, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Mesa Laboratories Inc?
The top five shareholders of Mesa Laboratories Inc are:
Conestoga Capital Advisors, LLC holds 566.15K shares, accounting for 10.29% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 708.66K shares, accounting for 12.88% of the total shares.
The Vanguard Group, Inc. holds 388.10K shares, accounting for 7.05% of the total shares.
Ranger Investment Management, L.P. holds 214.29K shares, accounting for 3.90% of the total shares.
Geneva Capital Management LLC holds 199.09K shares, accounting for 3.62% of the total shares.
Conestoga Capital Advisors, LLC holds 566.15K shares, accounting for 10.29% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 708.66K shares, accounting for 12.88% of the total shares.
The Vanguard Group, Inc. holds 388.10K shares, accounting for 7.05% of the total shares.
Ranger Investment Management, L.P. holds 214.29K shares, accounting for 3.90% of the total shares.
Geneva Capital Management LLC holds 199.09K shares, accounting for 3.62% of the total shares.
What are the top three shareholder types of Mesa Laboratories Inc?
The top three shareholder types of Mesa Laboratories Inc are:
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
How many institutions hold shares of Mesa Laboratories Inc (MLAB)?
As of 2025Q3, 387 institutions hold shares of Mesa Laboratories Inc, with a combined market value of approximately 5.12M, accounting for 92.75% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -9.10%.
What is the biggest source of revenue for Mesa Laboratories Inc?
In FY2026Q1, the Discrete Revenues- Consumables business generated the highest revenue for Mesa Laboratories Inc, amounting to 35.77M and accounting for 60.08% of total revenue.
